With the help of machine learning (ML) techniques, the possible errors made by the pathologists and physicians, such as those caused by inexperience, fatigue, stress and so on can be avoided, and the medical data can be examined in a shorter time and in a more detailed manner. However, while the conventional ML techniques, such as classification, achieved excellent performance in classification accuracy when applied in medical diagnoses, they have a fatal shortcoming of poor performance since the imbalanced dataset, especially for the detection of the minority category. To tackle the shortcomings of conventional classification approaches, this study proposes a novel ensemble learning paradigm for medical diagnosis with imbalanced data, which consists of three phases: data pre-processing, training base classifier and final ensemble. In the first data pre-processing phase, we introduce the extension of Synthetic Minority Oversampling Technique (SMOTE) by integrating it with cross-validated committees filter (CVCF) technique, which can not only synthesize the minority sample and thereby balance the input instances, but also filter the noisy examples so as to perform well in the process of classification. In the classification phase, we introduce ensemble support vector machine (ESVM) classification technique, which were constructed by multiple diversity structures of SVM classifiers and thus has the advantages of strong generalization performance and classification precision. Additionally, in the last phase of the final ensemble strategy, we introduce the weighted majority voting strategy and introduce simulated annealing genetic algorithm (SAGA) to optimize the weight vector and thereby enhance the overall classification performance. The efficiency of our proposed ensemble learning method was tested on nine imbalanced medical datasets and the experimental results clearly indicate that the proposed ensemble learning paradigm outperforms other state-of-the-art classification models. Promisingly, our proposed ensemble learning paradigm can effectively facilitate medical decision making for physicians.

As one of the most prevalent cancers among women worldwide, breast cancer has attracted the most attention by researchers. It has been verified that an accurate and early detection of breast cancer can increase the chances for the patients to take the right treatment plan and survive for a long time. Nowadays, numerous classification methods have been utilized for breast cancer diagnosis. However, most of these classification models have concentrated on maximum the classification accuracy, failed to take into account the unequal misclassification costs for the breast cancer diagnosis. To the best of our knowledge, misclassifying the cancerous patient as non-cancerous has much higher cost compared to misclassifying the non-cancerous as cancerous. Consequently, in order to tackle this deficiency and further improve the classification accuracy of the breast cancer diagnosis, we propose an improved cost-sensitive support vector machine classifier (ICS-SVM) for the diagnosis of breast cancer. In the proposed approach, we take full account of unequal misclassification costs of breast cancer intelligent diagnosis and provide more reasonable results over previous works and conventional classification models. To evaluate the performance of the proposed approach, Wisconsin Breast Cancer (WBC) and Wisconsin Diagnostic Breast Cancer (WDBC) breast cancer datasets obtained from the University of California at Irvine (UCI) machine learning repository have been studied. The experimental results demonstrate that the proposed hybrid algorithm outperforms all the existing methods. Promisingly, the proposed method can be regarded as a useful clinical tool for breast cancer diagnosis and could also be applied to other illness diagnosis.

Background: Online patient communities provide new channels for users to access and share medical information. In-depth study of users’ willingness to share information in online patient communities is of great significance for improving the level of information sharing among the patient community and the long-term development of communities. Objective: The aim of this study was to build a model of factors affecting patients’ willingness to share medical information from the perspective of both positive and negative utilities. Specifically, we aimed to determine the influence of online information support and privacy concerns, as well as the moderating effect of disease severity and information sensitivity of different patients on their willingness to share. Methods: Data from 490 users with experience in online patient communities were collected through a questionnaire survey, and structural equations were applied to empirically verify the model hypotheses. Results: Privacy concerns negatively affected the patients’ willingness to share information (P<.001), whereas online information support positively affected patients’ willingness to share information (P<.001), and information sensitivity negatively moderated the impact of online information support on sharing willingness (P=.01). Disease severity positively moderated the impact of privacy concerns on sharing willingness (P=.05). However, the hypotheses that information sensitivity is a negative moderator and disease severity is a positive moderator of the impact of privacy concerns on sharing willingness could not be supported. Conclusions: To improve the level of user information sharing, the online patient community should design a safe user registration process, ensure the confidentiality of information, reduce the privacy concerns of users, and accurately identify the information needs of patients to provide personalized support services.

In the context of the outbreak of coronavirus disease (COVID-19), this paper proposes an innovative and systematic decision support model based on Bayesian networks (BNs) to identify and control the risk of COVID-19 patients spreading the virus, which requires the following three steps. First, by consulting the related literature and combining this with expert knowledge, we identify and classify the characteristics (risk factors) of COVID-19 and obtain a conceptual framework for COVID-19 Risk Assessment Bayesian Networks (CRABNs). Second, data on COVID-19 patients with expert scoring results on patient risk levels were collected from hospitals in Hubei Province of China and are used as the training set, and the structure and parameters of the CRABNs model are obtained through machine learning. Finally, we propose two indicators, namely, Model Bias and Model Accuracy, and use the remaining data to verify the feasibility and effectiveness of the CRABNs model to ensure that there are no significant differences between the predicted results of the model and the actual results provided by experts who have relevant experience in treating COVID-19. At the same time, we compared the CRABNs model with the support vector machine (SVM), random forest (RF), and k-nearest neighbour (KNN) models through four indicators: accuracy, sensitivity, specificity, and F-score. The results suggest the reliability of the model and show that it has promising application potential. The proposed model can be used globally by doctors in hospitals as a decision support tool to improve the accuracy of assessing the severity of COVID-19 symptoms in patients. Furthermore, with the further improvement of the model in the future, it can be used for risk assessments in the field of epidemics.